Evidence Builds to Support Colchicine in Treating ASCVD Evidence Builds to Support Colchicine in Treating ASCVD
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Cardiology News Source Type: news
More News: Cardiology | Cardiovascular | Clinical Trials | Colchicine | Colcrys | Drugs & Pharmacology | Heart | Heart Attack